Publications

The following are medical publications on our technologies.

• Radiation dosimetry and biodistribution of ^99mTc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer.
• Technologies for Translational Imaging.
• Regional Radiochemotherapy Using In Situ Hydrogel.
• Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals.
• Assessment of Therapeutic Tumor Response Using ^99mTc-Ethylenedicysteine-Glucosamine.
• Radiation Dosimetry of ^99mTc-Labeled C225 in Patients with Squamous Cell Carcinoma of the Head and Neck.
• Assessment of cyclooxygense-2 expression with ^99mTc-labeled celebrex.
• Assessment of epidermal growth factor receptor with ^99mTc ethylenedicysteine C225 monoclonal antibody.
• Imaging with ^99mTc ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents1 Radiology
• Prognostication of Recovery in Patients With Acute Ischemic Stroke Through the Use of Brain SPECT With Technetium-99m Labeled Metronidazole
• Assessment of Antiangiogenic Effect Using ^99mTc-EC-Endostatin
• In Vivo and In Vitro Measurement of Apoptosis in Breast Cancer Cells Using ^99mTc-EC-Annexin V
• Noninvasive Assessment of Tumor Hypoxia with ^99mTc Labeled Metronidazole